A comparison of the segmental analysis of sodium reabsorption during Ringer's and hyperoncotic albumin infusion in the rat.
Studies were designed to compare the segmental analysis of sodium reabsorption along the nephron during volume expansion with either 10% body weight Ringer's or 0.6% body weight hyperoncotic albumin. Total kidney and nephron glomerular filtration rate increased similarly with both, but urinary sodium excretion (12.7 vs. 4.0 mueq/min, P < 0.001) and fractional sodium excretion (5.0 vs. 1.6%, P < 0.001) increased to a greater extent with Ringer's. Fractional reabsorption of sodium in the proximal tubule was diminished in both groups but to a significantly greater extent during Ringer's (P < 0.005). Absolute reabsorption was inhibited only in the Ringer's group. Delivery of filtrate out of the proximal tubule was greater in the Ringer's studies, 45 vs. 37 nl/min (P < 0.001). However, both fractional and absolute sodium delivery to the early and late distal tubule were not significantly different in the two groups. Fractional reabsorption in the collecting duct decreased from 96% in hydropenia to 31% during Ringer's but fell only slightly to 80% in the albumin studies. Absolute collecting duct reabsorption was also greater in the albumin studies, 0.55 vs. 0.21 neq/min (P < 0.001), which could totally account for the difference in urinary sodium excretion between the two groups. (22)Na recovery in the final urine after end distal microinjections was 71% during Ringer's infusion and 34% during albumin (P < 0.001). From these data we conclude that: (a) Ringer's solution has a greater inhibitory effect on proximal tubular sodium reabsorption, and (b) in spite of this effect, differences in mucosal to serosal collecting duct sodium transport are primarily responsible for the greater natriuresis during Ringer's infusion.
D000418:Albumins / Q000008:administration & dosage*; D000818:Animals; D002122:Calcium Chloride / Q000008:administration & dosage*; D005919:Glomerular Filtration Rate; D006400:Hematocrit; D007275:Injections, Intravenous; D007444:Inulin / Q000097:blood / Q000652:urine; D007684:Kidney Tubules / Q000502:physiology*; D007686:Kidney Tubules, Distal / Q000502:physiology; D007687:Kidney Tubules, Proximal / Q000502:physiology; D008138:Loop of Henle / Q000502:physiology; D008297:Male; D008845:Microinjections; D009399:Nephrons / Q000502:physiology; D011188:Potassium / Q000097:blood / Q000652:urine; D011189:Potassium Chloride / Q000008:administration & dosage*; D051381:Rats; D012964:Sodium / Q000097:blood / Q000652:urine*; D012965:Sodium Chloride / Q000008:administration & dosage*; D012975:Sodium Isotopes; D014316:Tritium
D000418:Albumins; D012975:Sodium Isotopes; D014316:Tritium; D012965:Sodium Chloride; D011189:Potassium Chloride; D007444:Inulin; D012964:Sodium; D002122:Calcium Chloride; D011188:Potassium